Tibsovo Tablet, Film Coated
Product Images NDC 72694-617

4 FDA label images from Servier Pharmaceutical Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Tibsovo (NDC 72694-617). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Servier Pharmaceutical Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Tibsovo 01)

Chemical Structure (Tibsovo 01)
Chemical structure of ivosidenib, the active ingredient in TIBSOVO 250 mg film-coated tablets. The diagram depicts the molecular arrangement and bonds characteristic of ivosidenib's chemical composition.*
FDA Label Image

250 mg Tablet 60-count Bottle Label (Tibsovo 02)

250 mg Tablet 60-count Bottle Label (Tibsovo 02)
A Kaplan-Meier survival curve depicting overall survival probability over months for two patient groups: one treated with AG-120 plus azacitidine and a placebo plus azacitidine group. The chart includes censored data points and a table showing the number of patients at risk over time for each group.*
FDA Label Image

Chemical Structure (Tibsovo 03)

Chemical Structure (Tibsovo 03)
A Kaplan-Meier survival curve chart displaying progression-free survival (PFS) probability over time in months for TIBSOVO (ivosidenib) and placebo groups. The chart includes censored data points and a table showing the number of patients at risk for each group across the timeline up to 20 months.*
FDA Label Image

250 mg Tablet 60-count Carton Label (product Of Usa) (Tibsovo 04)

250 mg Tablet 60-count Carton Label (product Of Usa) (Tibsovo 04)
TIBSOVO 250 mg film-coated tablets packaging label for oral administration contains 60 tablets. Manufactured for Servier Pharmaceuticals LLC, Boston, MA. The label shows the NDC 72694-617-60, dosage strength, and storage instructions, along with manufacturer trademarks and legal information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.